Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2013 May 28;11022:8906-11. doi: 10.1073/pnas.1214062110.
Show Gene links
Show Anatomy links
Multiple actions of phi-LITX-Lw1a on ryanodine receptors reveal a functional link between scorpion DDH and ICK toxins.
Smith JJ
,
Vetter I
,
Lewis RJ
,
Peigneur S
,
Tytgat J
,
Lam A
,
Gallant EM
,
Beard NA
,
Alewood PF
,
Dulhunty AF
.
???displayArticle.abstract???
We recently reported the isolation of a scorpion toxin named U1-liotoxin-Lw1a (U1-LITX-Lw1a) that adopts an unusual 3D fold termed the disulfide-directed hairpin (DDH) motif, which is the proposed evolutionary structural precursor of the three-disulfide-containing inhibitor cystine knot (ICK) motif found widely in animals and plants. Here we reveal that U1-LITX-Lw1a targets and activates the mammalian ryanodine receptor intracellular calcium release channel (RyR) with high (fM) potency and provides a functional link between DDH and ICK scorpion toxins. Moreover, U1-LITX-Lw1a, now described as ϕ-liotoxin-Lw1a (ϕ-LITX-Lw1a), has a similar mode of action on RyRs as scorpion calcines, although with significantly greater potency, inducing full channel openings at lower (fM) toxin concentrations whereas at higher pM concentrations increasing the frequency and duration of channel openings to a submaximal state. In addition, we show that the C-terminal residue of ϕ-LITX-Lw1a is crucial for the increase in full receptor openings but not for the increase in receptor subconductance opening, thereby supporting the two-binding-site hypothesis of scorpion toxins on RyRs. ϕ-LITX-Lw1a has potential both as a pharmacological tool and as a lead molecule for the treatment of human diseases that involve RyRs, such as malignant hyperthermia and polymorphic ventricular tachycardia.
Ahern,
Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.
1994, Pubmed
Ahern,
Single channel activity of the ryanodine receptor calcium release channel is modulated by FK-506.
1994,
Pubmed
Ali,
Malignant hyperthermia.
2003,
Pubmed
Bellinger,
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle.
2009,
Pubmed
Berridge,
Calcium signalling and Alzheimer's disease.
2011,
Pubmed
Bidasee,
Diketopyridylryanodine has three concentration-dependent effects on the cardiac calcium-release channel/ryanodine receptor.
2003,
Pubmed
Buck,
Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel.
1992,
Pubmed
Casarotto,
A structural requirement for activation of skeletal ryanodine receptors by peptides of the dihydropyridine receptor II-III loop.
2000,
Pubmed
Chen,
Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.
2003,
Pubmed
Clackson,
A hot spot of binding energy in a hormone-receptor interface.
1995,
Pubmed
Copello,
Heterogeneity of Ca2+ gating of skeletal muscle and cardiac ryanodine receptors.
1997,
Pubmed
Daly,
Bioactive cystine knot proteins.
2011,
Pubmed
Devor,
Unexplained peculiarities of the dorsal root ganglion.
1999,
Pubmed
Dulhunty,
Multiple actions of imperatoxin A on ryanodine receptors: interactions with the II-III loop "A" fragment.
2004,
Pubmed
Dulhunty,
The ryanodine receptor: a pivotal Ca2+ regulatory protein and potential therapeutic drug target.
2011,
Pubmed
Echols,
Comprehensive analysis of amino acid and nucleotide composition in eukaryotic genomes, comparing genes and pseudogenes.
2002,
Pubmed
El-Hayek,
Identification of the minimum essential region in the II-III loop of the dihydropyridine receptor alpha 1 subunit required for activation of skeletal muscle-type excitation-contraction coupling.
1998,
Pubmed
Estève,
Transduction of the scorpion toxin maurocalcine into cells. Evidence that the toxin crosses the plasma membrane.
2005,
Pubmed
Fields,
Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.
1990,
Pubmed
Fry,
The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms.
2009,
Pubmed
Gonzalez,
Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure.
2010,
Pubmed
Horita,
Solution structure of a short-chain insecticidal toxin LaIT1 from the venom of scorpion Liocheles australasiae.
2011,
Pubmed
Kimlicka,
The structural biology of ryanodine receptors.
2011,
Pubmed
Kimura,
Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
2005,
Pubmed
Koch,
The endoplasmic reticulum and calcium storage.
1990,
Pubmed
Laver,
Cytoplasmic Ca2+ inhibits the ryanodine receptor from cardiac muscle.
1995,
Pubmed
Lukács,
Charged surface area of maurocalcine determines its interaction with the skeletal ryanodine receptor.
2008,
Pubmed
Lü,
Involvement of ryanodine receptors in tetanic sciatic stimulation-induced long-term potentiation of spinal dorsal horn and persistent pain in rats.
2012,
Pubmed
Mabrouk,
Critical amino acid residues of maurocalcine involved in pharmacology, lipid interaction and cell penetration.
2007,
Pubmed
Martin,
Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.
1998,
Pubmed
McPherson,
Solubilization and biochemical characterization of the high affinity [3H]ryanodine receptor from rabbit brain membranes.
1990,
Pubmed
Meissner,
Ryanodine as a functional probe of the skeletal muscle sarcoplasmic reticulum Ca2+ release channel.
1992,
Pubmed
Melli,
Dorsal Root Ganglia Sensory Neuronal Cultures: a tool for drug discovery for peripheral neuropathies.
2009,
Pubmed
Mosbah,
A new fold in the scorpion toxin family, associated with an activity on a ryanodine-sensitive calcium channel.
2000,
Pubmed
Otsu,
Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum.
1990,
Pubmed
Pessah,
Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides.
1987,
Pubmed
Priori,
Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
2001,
Pubmed
Ram,
Design of a disulfide-less, pharmacologically inert, and chemically competent analog of maurocalcine for the efficient transport of impermeant compounds into cells.
2008,
Pubmed
Rodríguez de la Vega,
Overview of scorpion toxins specific for Na+ channels and related peptides: biodiversity, structure-function relationships and evolution.
2005,
Pubmed
Rush,
Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons.
2007,
Pubmed
Schwartz,
Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors.
2009,
Pubmed
Seo,
Both basic and acidic amino acid residues of IpTx(a) are involved in triggering substate of RyR1.
2011,
Pubmed
Smith,
Unique scorpion toxin with a putative ancestral fold provides insight into evolution of the inhibitor cystine knot motif.
2011,
Pubmed
Sun,
The preference of tryptophan for membrane interfaces: insights from N-methylation of tryptophans in gramicidin channels.
2008,
Pubmed
Tae,
Cyclization of the intrinsically disordered α1S dihydropyridine receptor II-III loop enhances secondary structure and in vitro function.
2011,
Pubmed
Takano,
An X-linked channelopathy with cardiomegaly due to a CLIC2 mutation enhancing ryanodine receptor channel activity.
2012,
Pubmed
Tripathy,
Imperatoxin A induces subconductance states in Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.
1998,
Pubmed
Ullrich,
PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity.
2012,
Pubmed
Wang,
Discovery and characterization of a family of insecticidal neurotoxins with a rare vicinal disulfide bridge.
2000,
Pubmed
Yotsu-Yamashita,
The structure of zetekitoxin AB, a saxitoxin analog from the Panamanian golden frog Atelopus zeteki: a potent sodium-channel blocker.
2004,
Pubmed
,
Xenbase
Zhu,
Evolutionary origin of inhibitor cystine knot peptides.
2003,
Pubmed
Zorzato,
Molecular cloning of cDNA encoding human and rabbit forms of the Ca2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum.
1990,
Pubmed
el-Hayek,
Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms.
1995,
Pubmed
